Genetic Risk Profiling and Prediction of Disease Course in Crohn's Disease Patients Liesbet Henckaerts, Kristel Van Steen, Isabel Verstreken, Isabelle.

Slides:

Advertisements

Similar presentations

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.

Advertisements

Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis Maria Theresa Arias, Niels Vande Casteele, Séverine Vermeire,

The Role of Psychosocial Care in Adapting to Health Care Reform

Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease David Drobne, Peter Bossuyt,

Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease David Drobne, Peter Bossuyt,

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Ruben Hernaez, MD, MPH, PhD Clinical Gastroenterology and Hepatology

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Volume 129, Issue 6, Pages (December 2005)

James W.T. Toh, Hasitha Balasuriya, Peter Stewart

Gauree Gupta, Ebbing Lautenbach, James D. Lewis

Katsunori Matsueda, Tatsuya Toyokawa

A Shocking Cystory Clinical Gastroenterology and Hepatology

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis Maria Theresa Arias, Niels Vande Casteele, Séverine Vermeire,

Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients Marko Brinar, Séverine.

Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study Harry Wu, Geoffrey C. Nguyen Clinical.

Rebekah S. Wieland, Richard S. Zubarik, Maryam J. Zenali

A 31-Year-Old Patient With Colitis and Perianal Disease

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease Matthias Jürgens, Jestinah M. Mahachie.

A 5-Year Prospective Observational Study of the Outcomes of International Treatment Guidelines for Crohn's Disease Garret Cullen, Denise Keegan, Hugh.

Long-term Recurrence-free Survival After Standard Endoscopic Resection Versus Surgical Resection of Submucosal Invasive Colorectal Cancer: A Population-based.

Wireless Capsule Endoscopy Fragmentation in a Patient With Crohn's Disease Marcia Henriques de Magalhães Costa, Andre da Luz Moreira, Cyrla Zaltman Clinical.

Leigh Ann White, Joseph Menzin, Jonathan R

Talya Salz, Robert S. Sandler Clinical Gastroenterology and Hepatology

Racial and Ethnic Differences in Presentation, Etiology, and Outcomes of Acute Liver Failure in the United States Kimberly A. Forde, K. Rajender Reddy,

Clinical Features, Treatment, and Survival of Patients With Colorectal Cancer With or Without Inflammatory Bowel Disease Raja Affendi Raja Ali, Cara.

Patrick B. Allen, Paul J. Kettle, Inder Mainie

Activity-Based Costing and Management in a Hospital-Based GI Unit

Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased Fiona D.M. van Schaik, Martijn G.H.

Amie L. Harvey, Tommy Yen, Anand Kunda

Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q

Obstructive Jaundice Caused by Intraductal Hepatocellular Carcinoma

New Models of Gastroenterology Practice

Impact of Liver Disease, Alcohol Abuse, and Unintentional Ingestions on the Outcomes of Acetaminophen Overdose Robert P. Myers, Abdel Aziz M. Shaheen,

Patients With Celiac Disease and B-Cell Lymphoma Have a Better Prognosis Than Those With T-Cell Lymphoma Thorvardur R. Halfdanarson, Alberto Rubio–Tapia,

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

Effects of Serum Aspartate Aminotransferase Levels in Patients With Autoimmune Hepatitis Influence Disease Course and Outcome Thawab Al–Chalabi, James.

Intragastric Fistula After Multiple Sphere Magnet Ingestion

David H. Bruining, William J. Sandborn

Najat Mourra, Nikias Colignon Clinical Gastroenterology and Hepatology

Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging Konstantinos Karmiris, Didier.

Patient-Reported Outcomes of Cirrhosis

Long-term Outcome of Perianal Fistulizing Crohn's Disease Treated With Infliximab Guillaume Bouguen, Laurent Siproudhis, Emmanuel Gizard, Timothée Wallenhorst,

Colorectal Cancer Screening: How to Stop a Moving Target

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Siddharth.

Is Biliary Microlithiasis a Significant Cause of Idiopathic Recurrent Acute Pancreatitis? A Long-term Follow-up Study Pramod Kumar Garg, Rakesh Kumar.

Issue Highlights Clinical Gastroenterology and Hepatology

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity Severine Vermeire, Stefan Schreiber,

Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis David N. Moskovitz, Gert Van Assche,

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Patrick Yachimski, William P. Puricelli, Norman S. Nishioka

Christopher Hung, Desmond Leddin

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism? John S. Leeds, David S. Sanders

Issue Highlights Clinical Gastroenterology and Hepatology

Coloduodenal Fistula in Crohn’s Disease

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Medical Therapy for Refractory Pediatric Crohn’s Disease

Thomas G. Cotter, John S. Van Arnam, John A. Schaffner

Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F

Rintaro Hashimoto, Akimichi Chonan

The Role of Psychosocial Care in Adapting to Health Care Reform

Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies Robert D. Mair, Antonia Valenzuela, Nghiem B.

Jordan E. Axelrad, Simon Lichtiger, Amrita Sethi

Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N

Presentation transcript:

Genetic Risk Profiling and Prediction of Disease Course in Crohn's Disease Patients Liesbet Henckaerts, Kristel Van Steen, Isabel Verstreken, Isabelle Cleynen, Andre Franke, Stefan Schreiber, Paul Rutgeerts, Séverine Vermeire Clinical Gastroenterology and Hepatology Volume 7, Issue 9, Pages 972-980.e2 (September 2009) DOI: 10.1016/j.cgh.2009.05.001 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Kaplan–Meier cumulative survival plots for time to first stricture (A), first non-perianal fistula (B), first perianal fistula (C), and first IBD-related operation (D). P values were obtained by log-rank testing. Separate analyses included only patients without the relevant outcome parameter at baseline. Clinical Gastroenterology and Hepatology 2009 7, 972-980.e2DOI: (10.1016/j.cgh.2009.05.001) Copyright © 2009 AGA Institute Terms and Conditions